WHO conditionally recommends GLP-1 drugs for long-term obesity treatment
Tuesday 2 December 2025 · 2 outlets · 2 reports · updated 
The World Health Organization has released its first guidelines regarding GLP-1 medications, such as Ozempic and Wegovy. These drugs are conditionally recommended for adults as part of a comprehensive approach to obesity that includes exercise, healthy diets, and professional health support.